Related Experiment Videos
Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy
1Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Abstract:
C3 nephritic factor (C3 NeF) has been found mainly in the sera of patients with membranoproliferative glomerulonephritis (MPGN) and partial lipodystrophy (PLD). We examined whether peripheral blood mononuclear cells (PBMC) from a patient with PLD could produce C3 NeF. We investigated the in vitro immunoglobulin synthesis of PBMC with mitogen. We further studied the C3bBb stabilizing activity and undertook agglutination assays of the IgG obtained from the culture supernatants. The patient IgG was able to agglutinate only EAC4b3bBb cells and none of the other intermediate cells. We this demonstrated that C3 NeF could be produced in vitro by PBMC derived from a patient with PLD.
Insights
Peripheral blood mononuclear cells from a patient with partial lipodystrophy can produce C3 nephritic factor (C3 NeF) in vitro. This finding demonstrates an in vitro production of C3 NeF by these cells.
Area of Science:
- Immunology
- Nephrology
Background:
- C3 nephritic factor (C3 NeF) is primarily associated with membranoproliferative glomerulonephritis (MPGN) and partial lipodystrophy (PLD).
- The cellular source and in vitro production of C3 NeF in PLD remain largely uncharacterized.
Observation:
- Peripheral blood mononuclear cells (PBMC) were isolated from a patient diagnosed with partial lipodystrophy.
- In vitro immunoglobulin synthesis assays were performed on PBMC stimulated with mitogens.
- The C3bBb stabilizing activity of culture supernatants and patient-derived IgG was assessed.
Findings:
- Patient-derived PBMC demonstrated the capacity for in vitro immunoglobulin synthesis.
- The isolated IgG exhibited specific C3bBb stabilizing activity.
- Agglutination assays confirmed the ability of patient IgG to interact with specific complement intermediates (EAC4b3bBb cells).
Implications:
- This study demonstrates that peripheral blood mononuclear cells from patients with partial lipodystrophy can produce C3 nephritic factor in vitro.
- These findings suggest a potential cellular mechanism contributing to complement dysregulation in PLD.
- Further research into PBMC-derived C3 NeF may offer new therapeutic targets for complement-mediated diseases.